SEC filings and other documents

Strong Q2 driven by 3870 pump demand; bookings, backlog, and guidance all point to robust growth.

Record Q2 revenue and FDA clearance of new pump drive raised 2025 outlook and future growth.

Record Q4 revenue and strong margins set the stage for major growth with the 3870 pump launch.

Record Q2 results and FDA clearance of new pump drive raised outlook and strong future growth.

Record Q2 results and FDA-cleared 3870 pump drive raised outlook and strong future growth.

Q1 2025 delivered record revenue and earnings, with strong pump and disposable growth.

New MRI-safe IV pump launch and facility expansion set stage for rapid multi-year growth.

Record revenue and earnings growth driven by pumps, with strong 2025 outlook and stable margins.

Record Q3 revenue and raised 2024 guidance, with strong pump sales and margin performance.

Record Q2 revenue and margin growth driven by strong pump sales and robust outlook.